{"title":"Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”","authors":"","doi":"10.1002/advs.202414927","DOIUrl":null,"url":null,"abstract":"<p>Mai J, Li Z, Xia X, Zhang J, Li J, Liu H, Shen J, Ramirez M, Li F, Li Z, Yokoi K, Liu X, Mittendorf EA, Ferrari M, Shen H. Adv Sci (Weinh). 2021, 8:2100166.</p><p>https://doi.org/10.1002/advs.202100166</p><p>In paragraph 1 of the “Discussion and Conclusion” section, a new reference “B. Temizoz, E. Kuroda, K. Ohata, N. Jounai, K. Ozasa, K. Kobiyama, T. Aoshi, and K.J. Ishii, Eur J Immunol. 2015, 45, 1159” is added after the text “… potentially as a result of crosstalk between the TLR and STING-mediated pathways and m-particle-activated TRIF/MAVS signaling”.</p><p>In paragraph 3 of the “Discussion and Conclusion” section, a new reference “C. Aroh, Z. Wang, N. Dobbs, M. Luo, Z. Chen, J. Gao, N. Yan, J Immunol. 2017, 199, 3840” is added after the text “In line with the study, it was previous found that a nanoparticle-based vaccine carrying a STING-activating polymer provided better therapeutic outcome than a polyIC-based vaccine.”</p><p>We apologize for missing these two references in the original article.</p>","PeriodicalId":117,"journal":{"name":"Advanced Science","volume":"12 8","pages":""},"PeriodicalIF":14.1000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/advs.202414927","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Science","FirstCategoryId":"88","ListUrlMain":"https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202414927","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Mai J, Li Z, Xia X, Zhang J, Li J, Liu H, Shen J, Ramirez M, Li F, Li Z, Yokoi K, Liu X, Mittendorf EA, Ferrari M, Shen H. Adv Sci (Weinh). 2021, 8:2100166.
https://doi.org/10.1002/advs.202100166
In paragraph 1 of the “Discussion and Conclusion” section, a new reference “B. Temizoz, E. Kuroda, K. Ohata, N. Jounai, K. Ozasa, K. Kobiyama, T. Aoshi, and K.J. Ishii, Eur J Immunol. 2015, 45, 1159” is added after the text “… potentially as a result of crosstalk between the TLR and STING-mediated pathways and m-particle-activated TRIF/MAVS signaling”.
In paragraph 3 of the “Discussion and Conclusion” section, a new reference “C. Aroh, Z. Wang, N. Dobbs, M. Luo, Z. Chen, J. Gao, N. Yan, J Immunol. 2017, 199, 3840” is added after the text “In line with the study, it was previous found that a nanoparticle-based vaccine carrying a STING-activating polymer provided better therapeutic outcome than a polyIC-based vaccine.”
We apologize for missing these two references in the original article.
李麦J, Z,夏X,张J,李J,刘H,沈J,拉米雷斯M,李,李Z,横井K,刘X,曼蒂EA,法拉利,沈H .副词Sci (Weinh)。201,8:2100166.https://doi.org/10.1002/advs.202100166In“讨论和结论”部分第1段，新增参考文献“B. .”Temizoz， E. Kuroda， K. Ohata， N. Jounai， K. Ozasa， K. Kobiyama， T. Aoshi， K.J. Ishii, Eur J.免疫学杂志，2015,45,1159“…可能是TLR和sting介导的通路和m粒子激活的TRIF/MAVS信号之间的串扰的结果”。在“讨论和结论”一节第3段中，增加了“C。Aroh, Wang Z.， N. Dobbs， M. Luo，陈振中，高军，颜宁，J.免疫学杂志，2017,3840”在“与研究一致，先前发现携带sting活化聚合物的纳米颗粒疫苗比基于polyic的疫苗具有更好的治疗效果。”我们很抱歉在原文中遗漏了这两个参考文献。
期刊介绍：
Advanced Science is a prestigious open access journal that focuses on interdisciplinary research in materials science, physics, chemistry, medical and life sciences, and engineering. The journal aims to promote cutting-edge research by employing a rigorous and impartial review process. It is committed to presenting research articles with the highest quality production standards, ensuring maximum accessibility of top scientific findings. With its vibrant and innovative publication platform, Advanced Science seeks to revolutionize the dissemination and organization of scientific knowledge.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
